前沿论文｜CELL INTELLIGENCE

Development of BCMA-Targeted Bispecific Natural Killer Cell Engagers for Multiple Myeloma Treatment.

PubMed 2024/11/29 发表Antibodies (Basel)Q3 · IF 3.3（JCR 2025）

Non-Conventional Allogeneic Anti-BCMA Chimeric Antigen Receptor-Based Immune Cell Therapies for Multiple Myeloma Treatment.

PubMed 2023/01/17 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

PubMed 2022/09/13 发表Blood AdvQ1 · IF 7.7（JCR 2025）

CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model.

PubMed 2021/09/01 发表Cancer Gene TherQ1 · IF 6.4（JCR 2025）

前沿论文 4